Study shows additional role for abiraterone in blocking tumor growth in CRPC
As part of an EU-supported IMI-PREDECT consortium (http://www.predect.eu), a Dutch study showed that anti-androgenic properties of the drug abiraterone may provide an additional mechanism of action in blocking tumour growth ...
Mar 15, 2013
0
0